FRONTAGE (01521) fell 2% to HK$1.44.
It hits an intra-day low of HK$1.44, hitting a historical low, and an intra-day high of HK$1.49. The total shares traded was 318,000, with a value of HK$464,960. The active buy/sell ratio is 23:77, with net selling turnover of HK$252,120. CITIGROUP GLOBAL accounts for greatest net responsive buying turnover of HK$143,390, with volume weighted average price of HK$1.462. UBS accounts for greatest net responsive selling turnover of HK$10,250, with volume weighted average price of HK$1.464. The stock has fallen a combined 8.3% over the past 5 consecutive trading days.
| Nominal | 1.440 | % Chg | -2.04% |
| High | 1.490 | Low | 1.440 |
| Shares Tr | 318,000 | Turnover | 464,960 |
| 10-D SMA | 1.529 | %H.V | 44.740 |
| 20-D SMA | 1.561 | VWAP | 1.462 |
| 50-D SMA | 1.703 | RSI14 | 33.462 |
| Stock (Code) | Price (HK$) | Change (%) |
|---|---|---|
| FRONTAGE (01521) | 1.44 | -2.04 |
| HUTCHMED (00013) | 26.70 | +0.56 |
| GENSCRIPT BIO (01548) | 14.42 | -0.41 |
| INNOVENT BIO (01801) | 38.10 | -1.17 |
| EVEREST MED-B (01952) | 22.25 | +3.25 |
| SIRNAOMICS-B (02257) | 9.61 | +8.22 |
| WUXI XDC (02268) | 17.52 | +5.42 |
| WUXI BIO (02269) | 13.90 | +2.51 |
| TIGERMED (03347) | 28.80 | +1.41 |
| AKESO (09926) | 45.95 | -2.13 |
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
